Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jorge Solimano
Observed name:
J Solimano
Institution:
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno
Observed institution:
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno
OpenAlex ID:
A5085022311
Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
2006
·
Juan M Rodriguez
, Fernanda Elias
, et al.
·
PubMed
·
10
Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease
2003
·
M Echavarria
, F Herrera
, et al.
·
Bone Marrow Transplantation
·
9
PDF
99m Technetium-SESTAMIBI Uptake in Malignant Lymphomas. Correlation with Chemotherapy Response
2006
·
Alberto Lazarowski
, Juan Dupont
, et al.
·
Lymphatic Research and Biology
·
8
Convalescent plasma as potential therapy for severe COVID-19 pneumonia
2020
·
Ricardo Valentini
, José Fernández
, et al.
·
medRxiv
·
5
PDF
[Convalescent plasma as a therapy for severe COVID-19 pneumonia].
2020
·
Ricardo Valentini
, José Fernández
, et al.
·
PubMed
·
3
[Coagulopathy and COVID-19. Recommendations for a changing reality].
2020
·
Dardo Riveros
, Daniela Maymó
, et al.
·
PubMed
·
2
Carotid and Vertebral Artery Dissection Syndromes.
2005
·
Beatriz Grand
, Jorge Solimano
, et al.
·
Blood
·
2
ONC001: A first-in-class ADC targeting CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selection
2025
·
Cintia Garro
, Lia Buffa
, et al.
·
Blood
PDF
AML-1231: Real-World Experience With Venetoclax as Part of the Conditioning Regimen for HSCT in Patients With High-Risk AML/MDS
2025
·
Paola Viola
, G Antelo
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1231 Real-World Experience With Venetoclax as Part of the Conditioning Regimen for HSCT in Patients With High-Risk AML/MDS
2025
·
Paola Viola
, G Antelo
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CT-1344: Real-World Experience With Ruxolitinib for Steroid-Refractory Acute Graft-vs-Host Disease in a Latin American Center
2025
·
Guadalupe Antelo Perez
, P Viola
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-1344 Real-World Experience With Ruxolitinib for Steroid-Refractory Acute Graft-vs-Host Disease in a Latin American Center
2025
·
Guadalupe Antelo Perez
, P Viola
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Functional Ex-Vivo Testing Combined with Machine Learning Predicts Clinical Response to Azacitidine+Venetoclax in AML
2023
·
Diego Andino
, Maria Laura Bernaschini
, et al.
·
Blood
PDF
Identification of Unexpected Responders to Gilteritinib in a Cohort of FLT3-WT AML Patients Using Ex-Vivo Testing
2023
·
Alejandra Garcia
, Laura Bertoldi
, et al.
·
Blood
Ex-Vivo Testing Using Patient Micro Avatars (PMAs) Predicts Clinical Response in Acute Leukemias
2022
·
Alejandra Garcia
, Lía Buffa
, et al.
·
Blood
“Sé lo que quiero, y estoy dispuesto a esperarlo”. Nacimiento de la Subcomisión de Economía y Salud de la Sociedad Argentina de Hematología
2022
·
Flavio Albarracin
, Jorge Solimano
·
Revista Hematología
Plasma de convalecientes como terapia para la neumonía por COVID-19 grave
2020
·
Ricardo Valentini
, José Luño Fernández
, et al.
·
Medicina-buenos Aires
Coagulopatía y Covid-19. Recomendaciones para una realidad cambiante
2020
·
Dardo Riveros
, Daniela Mymó
, et al.
·
Inmanencia. Revista del Hospital Interzonal General de Agudos (HIGA) Eva Perón
[Granulocytes transfusion for neutropenic patients].
2001
·
J Fernández
, V Pressiani
, et al.
·
PubMed
Show more works
View as search
Works count:
20
Citation count:
39
H-index:
4
I10-index:
1
Year
Topic
Type